Stock Events

Stock Events

Denali Therapeutics (D2NL34.SA) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-4.24

-3.95

-3.67

-3.38

Details

Expected EPS

-3.3768578376000002

Actual EPS

-3.575124

Surprise EPS

-0.2

Surprise Percent

+5.87%

Description

Denali Therapeutics (D2NL34.SA) has reported earnings of -3.575124 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.